Study on the risk signal mining related to edoxaban based on the US FDA Adverse Event Reporting System

Wang Yu, Li Jia, Pan Yunyan, Zheng Yifan, Chen Pan, Chen Jie

PDF(384 KB)
PDF(384 KB)
Adverse Drug Reactions Journal ›› 2022, Vol. 24 ›› Issue (7) : 347-352. DOI: 10.3760/cma.j.cn114015-20220515-00427

Study on the risk signal mining related to edoxaban based on the US FDA Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 24(7): 347-352 https://doi.org/10.3760/cma.j.cn114015-20220515-00427

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(384 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉